Key Takeaways
- With commercial insurance plus the Novo Nordisk savings card, most patients pay $25 per fill (a 4-week supply) for Ozempic.
- Without the savings card but with commercial coverage, monthly copays typically run $25 to $200 depending on plan tier and deductible status.
- Medicare Part D typically charges $40 to $120 a month for Ozempic when prescribed for diabetes. Medicare does not cover Ozempic for weight loss.
- Medicaid coverage varies by state, with copays usually $0 to $10 when Ozempic is on the preferred drug list.
- Cash list price is about $815 per pen (a 4-week supply) per April 2026 manufacturer pricing.
Direct answer (40-60 words)
With commercial insurance plus the Novo Nordisk savings card, most Ozempic patients pay $25 per month. Without the savings card, copays typically run $25 to $200. Medicare Part D copays run $40 to $120 a month for diabetes use only. Cash list price without coverage is about $815 a month per April 2026 pricing.
Table of contents
- The 30-second answer
- The list price you're starting from
- Commercial insurance: what most patients actually pay
- Medicare: rules, copays, and the weight-loss exclusion
- Medicaid: state-by-state variation
- Tricare and VA pricing
- The Novo Nordisk savings card explained
- Manufacturer patient assistance for low-income patients
- Why your pharmacy quote is different from your friend's
- How to lower your out-of-pocket cost step by step
- FAQ
- Sources
- Footer disclaimers
The list price you're starting from
Ozempic's wholesale acquisition cost (WAC) as of April 2026 is $935.77 per pen for the 0.5 mg/0.25 mg pen, $935.77 for the 1 mg pen, and $1,029.18 for the 2 mg pen. Each pen is a 4-week supply at the labeled dose.
See transparent compounded pricing
Review compounded GLP-1 pricing and what provider-reviewed care includes, with no surprises at checkout.
Try the Cost Calculator →What you actually pay depends on negotiations between your insurance plan, the pharmacy benefit manager (PBM), and the manufacturer. The list price is just the starting number on which discounts and rebates are calculated.
When pharmacies quote Ozempic at "$1,000 a month" or "$815 a month," they're quoting the cash price, which is the list price minus the pharmacy's small markup adjustment. The cash price is what you'd pay if you walked in with no insurance and no coupons. Almost no one actually pays this, but it's the reference point.
Commercial insurance: what most patients actually pay
If you have employer-sponsored or marketplace insurance, your Ozempic cost depends on three things:
- Whether your plan covers Ozempic at all
- What tier Ozempic sits on within your plan's formulary
- Whether you've met your deductible
Coverage status (2026 typical):
About 90% of commercial plans cover Ozempic for type 2 diabetes. Coverage requires prior authorization in most cases, meaning your provider has to submit documentation showing diagnosis of T2D and usually a trial of metformin first.
About 30% of commercial plans cover Ozempic-class GLP-1s for weight loss alone (without a diabetes diagnosis). The number has been rising. Some plans cover Wegovy specifically (the weight-loss-indicated semaglutide) but not off-label Ozempic for weight loss.
Tier placement and typical copays:
| Plan tier | Description | Monthly copay range |
|---|---|---|
| Tier 2 (preferred brand) | Best placement | $25 to $50 |
| Tier 3 (non-preferred brand) | Most common | $40 to $100 |
| Tier 4 (specialty) | High-cost specialty | $100 to $300 |
| Coinsurance plan | Percentage-based | 20% to 40% of contracted price |
| Deductible not met | High-deductible plan, pre-deductible | Up to full contracted price (often $400 to $700) |
If you have a high-deductible health plan and haven't hit your deductible yet, you may pay close to the contracted (negotiated) price for Ozempic, which often runs $400 to $700 a month. After you hit deductible, you pay your tier copay or coinsurance.
The savings card on top of insurance.
If you have commercial insurance and Ozempic is covered, the Novo Nordisk savings card can drop your copay to as low as $25 per fill, with a maximum savings of $150 per fill and a $1,800 annual benefit cap. The card stacks with your insurance: insurance pays first, the card covers most of what's left, you pay $25.
The savings card is excluded for Medicare, Medicaid, Tricare, and Veterans Affairs patients per federal anti-kickback rules.
Medicare: rules, copays, and the weight-loss exclusion
Medicare Part D plans cover Ozempic for type 2 diabetes. Coverage usually requires prior authorization. Per April 2026 plan data, average copays look like this:
| Coverage phase | Typical copay/month |
|---|---|
| Initial coverage (after deductible, before $5,030 spend) | $40 to $120 |
| Coverage gap (closed for most plans in 2025) | Plan-dependent, around 25% coinsurance historically |
| Catastrophic coverage (after $2,000 out-of-pocket cap, new in 2025) | $0 |
The Inflation Reduction Act capped Medicare Part D patient out-of-pocket spend at $2,000 per year starting January 2025. After you've spent $2,000 on covered drugs, your remaining Medicare Rx costs for the year are $0. For patients on multiple expensive drugs including Ozempic, this matters a lot.
The weight-loss exclusion.
Medicare does not cover Ozempic when prescribed for weight loss without a diabetes diagnosis. The Social Security Act explicitly excludes drugs for "anorexia, weight loss, or weight gain" from Part D coverage. CMS has interpreted this to exclude GLP-1s when the indication is obesity or overweight without comorbidity.
There's an exception: as of 2024, CMS issued guidance allowing Wegovy coverage when prescribed to reduce cardiovascular risk in patients with overweight/obesity plus established cardiovascular disease (the SELECT trial indication). This exception applies to Wegovy specifically, not off-label Ozempic.
If a Medicare beneficiary has type 2 diabetes, Ozempic is covered. If not, it's not, regardless of how the prescription is written.
Medicaid: state-by-state variation
Medicaid coverage of Ozempic varies by state. Most states cover it for type 2 diabetes with prior authorization. Some states cover GLP-1s for weight loss with stricter criteria.
Typical Medicaid copays (when covered):
- $0 to $4 in most states for preferred-formulary drugs
- $1 to $10 for non-preferred drugs
- Some states charge no copay at all for Medicaid expansion enrollees below certain income thresholds
If your state Medicaid does not cover Ozempic for your indication, the manufacturer savings card cannot be used (Medicaid is excluded). Your options are:
- Ask your provider whether a covered alternative (such as a different GLP-1 on the preferred drug list) makes sense
- Apply for Novo Nordisk patient assistance (see below)
- Pay cash with a pharmacy discount card (rarely below $700 a month)
State formularies change. Check your specific Medicaid plan's preferred drug list each year.
Tricare and VA pricing
Tricare covers Ozempic for type 2 diabetes with prior authorization. Active-duty service members typically pay $0; family members and retirees pay $0 to $34 for a 30-day supply at military or network pharmacies depending on tier.
VA prescription benefit covers Ozempic for veterans enrolled in VA healthcare when prescribed by a VA provider. Copays for VA-prescribed medications run $0 to $11 per 30-day supply per priority group as of 2026, with annual caps. The savings card is excluded.
The Novo Nordisk savings card explained
Mechanics of the card (as published, April 2026):
- Eligibility: Commercial insurance covering Ozempic. US residents only. Excludes Medicare, Medicaid, Tricare, VA, and any other government insurance.
- Pay as little as $25 per 1-, 2-, or 3-month prescription fill if your commercial insurance covers Ozempic.
- Maximum savings: $150 per 1-month fill, $300 per 2-month fill, $450 per 3-month fill.
- Annual benefit cap: $1,800 of total savings per calendar year.
- No income requirement. Anyone with eligible commercial insurance qualifies.
- Activation: Sign up at the Ozempic site, get a card with a BIN/PCN/group number, present at pharmacy.
The math example: if your tier copay would be $300 a month and the card caps savings at $150, you pay $150. If your copay is $50, the card pays $25 and you pay $25 (the floor). If your insurance won't cover Ozempic at all (denial), the card doesn't apply, because the card requires the claim to process through commercial insurance first.
A common pitfall: the card doesn't help if your deductible isn't met and your contracted price is, say, $700. The card can save up to $150 per fill, so you'd still pay around $550 until your deductible is met. After deductible, the card brings you to your tier copay or to the $25 floor.
Manufacturer patient assistance for low-income patients
Novo Nordisk's Patient Assistance Program (PAP) provides free Ozempic to qualifying low-income patients. Eligibility (April 2026):
- US resident or legal alien
- Total household income at or below 400% of federal poverty level (currently about $60,240 for an individual, $124,800 for a family of four)
- No prescription drug coverage, or prescription coverage that has been exhausted/won't cover Ozempic
- Not eligible for federal/state programs that would cover the drug
Application requires provider involvement. Approval is typically valid for 12 months and renewable. Free drug ships to your provider's office.
If you've been quoted $700+ a month for Ozempic and your income qualifies, this is worth applying to. Approval rates are reasonably high for clearly uninsured low-income patients with a documented diagnosis of T2D.
Why your pharmacy quote is different from your friend's
Several factors create the wide variation in what people pay:
- Plan formulary tier. A friend on a tier-2 plan pays less than you on a tier-4 plan, all else equal.
- Deductible status. If you haven't hit deductible, you pay close to the contracted rate; your friend who hit theirs in February pays the tier copay.
- Pharmacy benefit manager (PBM) negotiated rate. Different employers negotiate different prices. Same plan name doesn't always mean same price.
- Pharmacy choice. Some plans require mail-order or preferred network pharmacies for lowest pricing. Filling at an out-of-network pharmacy can mean paying retail.
- Whether you used the savings card. Some people don't know the card exists.
- Geographic region. Pricing can vary by state due to local market dynamics.
- Refill timing. A 90-day mail-order fill is often cheaper per month than three 30-day retail fills.
If your quote seems much higher than expected, ask the pharmacy: (1) is this with my insurance, (2) what's my plan-contracted price vs the listed cost, (3) have I met my deductible, and (4) does my plan have a preferred pharmacy network.
How to lower your out-of-pocket cost step by step
Step 1: Confirm Ozempic is covered. Call your insurance member services. Ask whether Ozempic is on formulary, what tier, and whether prior authorization is required. If yes to coverage with PA, your provider's office submits the PA paperwork.
Step 2: Get the savings card if you have commercial insurance. Sign up online; takes 2 minutes. Bring the card to the pharmacy. Confirm the pharmacy applied it before paying.
Step 3: Use a 90-day mail-order fill if your plan offers one. Most commercial plans charge 2 to 2.5x your monthly copay for a 90-day fill, which works out to a meaningful per-month discount.
Step 4: If denied, appeal. Insurance denials of Ozempic for documented type 2 diabetes are usually overturnable on appeal. Your provider's office can submit clinical documentation.
Step 5: Look at alternatives if cost stays high. If insurance won't cover or copay is unaffordable:
- Generic liraglutide (FDA-approved December 2024) may be cheaper and is the same class
- Other covered GLP-1s on your plan
- Compounded semaglutide through a state-licensed compounding pharmacy in response to an individual prescription. Compounded semaglutide is not FDA-approved, is prepared in response to an individual prescription, and is not interchangeable with Ozempic. Pricing varies by provider.
- Apply for Novo Nordisk patient assistance if income qualifies
Step 6: Reassess each year. Plan formularies change annually. The drug that was tier 4 last year may be tier 2 this year. Re-check during open enrollment.
FAQ
How much does Ozempic cost with insurance? Most commercial-insurance patients pay $25 to $300 a month, and as little as $25 with the manufacturer savings card. Medicare Part D copays run $40 to $120. Medicaid copays usually run $0 to $10 when covered.
Is Ozempic covered by insurance? Most commercial plans cover Ozempic for type 2 diabetes with prior authorization. Coverage for weight loss alone is less common. Medicare Part D covers it for diabetes only. Medicaid coverage varies by state.
How much is Ozempic without insurance? Cash list price is about $815 to $935 per pen (a 4-week supply) per April 2026 manufacturer pricing. Without insurance, the savings card cannot be used, but the Novo Nordisk Patient Assistance Program may provide free Ozempic to qualifying low-income patients.
Why is my Ozempic copay so high? Common reasons: high-deductible plan with deductible not met, tier-4 specialty placement, no savings card applied, or out-of-network pharmacy. Call member services to verify your tier and deductible status.
Does Medicare cover Ozempic for weight loss? No. Medicare excludes drugs prescribed for weight loss alone. Medicare covers Ozempic when prescribed for type 2 diabetes. Wegovy has limited coverage for cardiovascular risk reduction in eligible patients.
Can I use a savings card with Medicare? No. Manufacturer savings cards are excluded for Medicare, Medicaid, Tricare, and VA patients per federal anti-kickback rules. Medicare patients should look at Part D plan optimization and the $2,000 out-of-pocket cap instead.
How much is Ozempic with Tricare? Tricare covers Ozempic for diabetes with prior authorization. Active-duty service members typically pay $0. Family members and retirees pay $0 to $34 for a 30-day supply per April 2026 formulary tiers.
Why does my pharmacy quote keep changing? Quotes change with deductible status, refill timing, formulary updates, and whether the savings card is applied. The same patient on the same plan can see a 10x variation across the year.
Can I get Ozempic for $25 a month? Yes, if you have commercial insurance covering Ozempic and use the Novo Nordisk savings card. The card brings most copays down to $25, capped at $150 of savings per fill and $1,800 a year.
What if my insurance denies Ozempic? Appeal. Most denials of Ozempic for documented type 2 diabetes are overturnable. Your provider's office handles the prior authorization and appeal paperwork. Document failure of metformin or other prior therapies as needed.
Is there a generic for Ozempic? Not yet. Generic semaglutide (the active ingredient in Ozempic) is not FDA-approved as of April 2026. Generic liraglutide (the active ingredient in Victoza, a related GLP-1) was approved in December 2024 and is available at lower cost.
Will my plan cover Ozempic for weight loss? About 30% of commercial plans cover GLP-1s for weight loss alone (no diabetes diagnosis). Coverage usually requires BMI 30+, or 27+ with comorbidity, plus documented prior weight-loss attempts. Medicare and most Medicaid plans do not cover off-label use of Ozempic for weight loss.
Sources
- Novo Nordisk. Ozempic prescribing information, revised 2024.
- Novo Nordisk. Ozempic Savings Card terms and conditions, April 2026.
- Centers for Medicare & Medicaid Services. Inflation Reduction Act prescription drug provisions, 2025 implementation.
- Centers for Medicare & Medicaid Services. Medicare Part D drug coverage rules, 2026.
- Kaiser Family Foundation. GLP-1 coverage in commercial and Medicare plans, 2025 analysis.
- American Diabetes Association. Standards of Care in Diabetes 2025. Diabetes Care. 2025;48(Suppl 1).
- CMS. Medicare coverage policy guidance on Wegovy, March 2024.
- Defense Health Agency. Tricare formulary search, April 2026 update.
- Department of Veterans Affairs. VA pharmacy copay rates, fiscal year 2026.
- Marso SP, et al. Semaglutide and cardiovascular outcomes (SUSTAIN 6). N Engl J Med. 2016;375:1834-1844.
- Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT). N Engl J Med. 2023;389:2221-2232.
- Novo Nordisk Patient Assistance Program eligibility guidelines, April 2026.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Ozempic, Wegovy, and Victoza are registered trademarks of Novo Nordisk A/S. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →